ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001290165

QVT Fund LP

CIK 0001290165 Name as filed on the most recent filing

Filed as QVT Fund LP (42)

84 transaction lines · from 42 filings · filed 2009-09-24 to 2011-10-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2011-10-21 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 364,918 disposed 3.68 1,342,898.24 Form 4, filing 0001209191-11-052489
2011-10-20 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 5,252,700 disposed 3.68 19,329,936.00 Form 4, filing 0001209191-11-052489
2011-10-17 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 650,100 disposed 3.68 2,392,368.00 Form 4, filing 0001209191-11-052181
2011-09-27 Inhibitex, Inc.
INHX 		S, Open-market sale 200,000 disposed 3.00 600,000.00 Form 4, filing 0001209191-11-049240
2011-09-26 Inhibitex, Inc.
INHX 		S, Open-market sale 30,000 disposed 2.97 89,100.00 Form 4, filing 0001209191-11-049240
2011-09-26 Inhibitex, Inc.
INHX 		S, Open-market sale 2,500 disposed 3.01 7,525.00 Form 4, filing 0001209191-11-049240
2011-09-26 Inhibitex, Inc.
INHX 		S, Open-market sale 1,400 disposed 3.10 4,340.00 Form 4, filing 0001209191-11-049240
2011-05-31 Inhibitex, Inc.
INHX 		S, Open-market sale 600,000 disposed 4.49 2,694,000.00 Form 4, filing 0001181431-11-034497
2011-05-31 Inhibitex, Inc.
INHX 		S, Open-market sale 55,000 disposed 4.58 251,900.00 Form 4, filing 0001181431-11-034497
2011-04-11 Inhibitex, Inc.
INHX 		S, Open-market sale 78,335 disposed 4.29 336,057.15 Form 4, filing 0001181431-11-023524
2011-04-11 Inhibitex, Inc.
INHX 		S, Open-market sale 60,717 disposed 4.28 259,868.76 Form 4, filing 0001181431-11-023524
2011-04-08 Inhibitex, Inc.
INHX 		S, Open-market sale 230,000 disposed 4.37 1,005,100.00 Form 4, filing 0001181431-11-023524
2011-04-08 Inhibitex, Inc.
INHX 		S, Open-market sale 105,382 disposed 4.39 462,626.98 Form 4, filing 0001181431-11-023524
2011-04-07 Inhibitex, Inc.
INHX 		S, Open-market sale 129,757 disposed 4.52 586,501.64 Form 4, filing 0001181431-11-023524
2011-01-03 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 34,209 acquired 1.41 48,234.69 Form 4, filing 0001181431-11-002006
2010-12-31 TPC Group Inc.
TPCG 		S, Open-market sale 14,000 disposed 30.77 430,780.00 Form 4, filing 0001181431-11-001356
2010-12-30 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 300 acquired 1.48 444.00 Form 4, filing 0001181431-11-000429
2010-12-29 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 267,014 acquired 1.45 387,170.30 Form 4, filing 0001181431-11-000429
2010-12-29 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 50,000 acquired 1.46 73,000.00 Form 4, filing 0001181431-11-000429
2010-12-28 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 532,490 acquired 1.44 766,785.60 Form 4, filing 0001181431-10-064096
2010-12-28 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 12,200 acquired 1.34 16,348.00 Form 4, filing 0001181431-10-064096
2010-12-28 TPC Group Inc.
TPCG 		S, Open-market sale 24,600 disposed 30.78 757,188.00 Form 4, filing 0001181431-10-064095
2010-12-27 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 1,714,210 acquired 1.30 2,228,473.00 Form 4, filing 0001181431-10-064096
2010-12-27 TPC Group Inc.
TPCG 		S, Open-market sale 49,000 disposed 30.85 1,511,650.00 Form 4, filing 0001181431-10-064095
2010-12-23 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 285,790 acquired 1.21 345,805.90 Form 4, filing 0001181431-10-063627
2010-10-20 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 150,000 acquired 1.65 247,500.00 Form 4, filing 0001181431-10-051764
2010-10-15 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 1,951,389 acquired 1.80 3,512,500.20 Form 4, filing 0001181431-10-051388
2010-10-15 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 150,000 acquired 1.65 247,500.00 Form 4, filing 0001181431-10-051388
2010-10-15 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 90,000 acquired 1.68 151,200.00 Form 4, filing 0001181431-10-051388
2010-10-15 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 85,000 acquired 1.66 141,100.00 Form 4, filing 0001181431-10-051388
2010-10-15 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 25,000 acquired 1.67 41,750.00 Form 4, filing 0001181431-10-051388
2010-09-16 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 8,000 acquired 1.78 14,240.00 Form 4, filing 0001181431-10-047373
2010-09-10 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 25,000 acquired 1.80 45,000.00 Form 4, filing 0001181431-10-046635
2010-09-01 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 25,000 acquired 1.74 43,500.00 Form 4, filing 0001181431-10-045633
2010-08-30 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 25,000 acquired 1.77 44,250.00 Form 4, filing 0001181431-10-044955
2010-08-27 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 6,000 acquired 1.75 10,500.00 Form 4, filing 0001181431-10-044955
2010-08-26 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 15,700 acquired 1.75 27,475.00 Form 4, filing 0001181431-10-044660
2010-08-25 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 17,400 acquired 1.70 29,580.00 Form 4, filing 0001181431-10-044660
2010-08-24 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 34,900 acquired 1.73 60,377.00 Form 4, filing 0001181431-10-044156
2010-08-23 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 27,000 acquired 1.79 48,330.00 Form 4, filing 0001181431-10-044156
2010-08-20 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 4,000 acquired 1.77 7,080.00 Form 4, filing 0001181431-10-043180
2010-08-19 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 16,000 acquired 1.79 28,640.00 Form 4, filing 0001181431-10-043180
2010-08-17 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 5,000 acquired 1.80 9,000.00 Form 4, filing 0001181431-10-042474
2010-08-16 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 35,000 acquired 1.86 65,100.00 Form 4, filing 0001181431-10-042474
2010-08-12 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 32,500 acquired 1.94 63,050.00 Form 4, filing 0001181431-10-042009
2010-08-03 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 50,400 acquired 1.99 100,296.00 Form 4, filing 0001181431-10-040566
2010-07-06 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 30,000 acquired 1.98 59,400.00 Form 4, filing 0001181431-10-036968
2010-07-02 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 56,800 acquired 1.94 110,192.00 Form 4, filing 0001181431-10-036521
2010-04-07 TPC Group Inc.
TPCP 		P, Open-market purchase 194,490 acquired 12.75 2,479,747.50 Form 4, filing 0001181431-10-020965
2009-12-16 Inhibitex, Inc.
INHX 		P, Open-market purchase 43,000 acquired 0.85 36,550.00 Form 4, filing 0001181431-09-057762

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. QVT Fund LP, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001290165

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.